ENCell Co., Ltd. (KOSDAQ:456070)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,370
-230 (-1.83%)
Jun 27, 2025, 3:30 PM KST
-64.76%
Market Cap 137.35B
Revenue 6.51B
Net Income -16.95B
Shares Out 10.90M
EPS -1,774.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 60,505
Average Volume 62,275
Open 12,490
Previous Close 12,600
Day's Range 12,360 - 12,590
52-Week Range 12,100 - 45,800
Beta n/a
RSI 35.58
Earnings Date n/a

About ENCell

ENCell Co., Ltd. develops cell/gene-based biopharmaceutical products in South Korea. The company develops EN00, an allogeneic umbilical cord-derived mesenchymal stem cell treatment for Charcot-Marie-Tooth disease It also provides contracting development and manufacturing services for biopharmaceutical products. The company was founded in 2018 and is based in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 456070
Full Company Profile

News

There is no news available yet.